MMR Vaccine for the Childhood Immunisation Programme

Folkehelseinstituttet

Folkehelseinstituttet [the Norwegian Institute of Public Health] is carrying out an open tender competition with the aim of entering into a framework agreement for the delivery of MMR vaccines. I.e. a combination vaccine against measles, mumps and rubella (living) for the Norwegian Childhood Immunisation Programme.
The competition is carried out as an open tender competition in accordance with the Public Procurement Regulations' Parts 1 and 3. The competition is implemented electronically in the CTM electronic tender documentation tool (Norwegian abbreviation: KGV).
There are four (4) minimum requirements for the vaccine.
The agreement includes the delivery of a combination vaccine against measles, mumps and rubella (living) (MMR) (ATC code: J07B D52)
The new agreement is valid from 1 June 2021. The contract will have a duration of 2 years with automatic extension for 1 year + 1 year unless it is cancelled earlier in-line with supply agreement point 17.
The delivery includes 540 000-660 000 doses during the maximum agreement period (4 years).

Frist

Fristen for mottak av tilbud var 2020-09-28. Anskaffelsen ble publisert 2020-07-22.

Leverandører

Følgende leverandører er nevnt i tildelingsbeslutninger eller andre anskaffelsesdokumenter:

Hvem? Hva? Hvor?
Anskaffelseshistorikk
Dato Dokument
2020-07-22 Kunngjøring av konkurranse
2021-01-15 Kunngjøring om tildeling av kontrakt
Kunngjøring av konkurranse (2020-07-22)
Gjenstand
Anskaffelsens omfang
Tittel: Measles-mumps-rubella vaccines
Referansenummer: 20/12527
Kort beskrivelse:
Folkehelseinstituttet [the Norwegian Institute of Public Health] is carrying out an open tender competition with the aim of entering into a framework agreement for the delivery of MMR vaccines. I.e. a combination vaccine against measles, mumps and rubella (living) for the Norwegian Childhood Immunisation Programme. The competition is carried out as an open tender competition in accordance with the Public Procurement Regulations' Parts 1 and 3. The competition is implemented electronically in the CTM electronic tender documentation tool (Norwegian abbreviation: KGV). There are four (4) minimum requirements for the vaccine. The agreement includes the delivery of a combination vaccine against measles, mumps and rubella (living) (MMR) (ATC code: J07B D52) The new agreement is valid from 1 June 2021. The contract will have a duration of 2 years with automatic extension for 1 year + 1 year unless it is cancelled earlier in-line with supply agreement point 17. The delivery includes 540 000-660 000 doses during the maximum agreement period (4 years).
Vis mer
Metadata for kunngjøring
Originalspråk: engelsk 🗣️
Dokumenttype: Kunngjøring av konkurranse
Kontraktens art: Varer
Forskrift: Det europeiske økonomiske samarbeidsområdet (EØS), med deltakelse av GPA-land
Felles innkjøpsordliste (CPV)
Kode: Vaksiner mot meslinger, kusma og røde hunder 📦
Tilleggs-CPV: Vaksiner 📦
Utførelsessted
NUTS-region: Norge 🏙️

Prosedyre
Prosedyretype: Åpen anbudskonkurranse
Tilbudstype: Innlevering for alle delkontrakter
Tildelingskriterier
Laveste pris

Oppdragsgiver
Identitet
Land: Norge 🇳🇴
Type tildelende myndighet: Departement eller annen nasjonal eller føderal myndighet
Navn på tildelende myndighet: Folkehelseinstituttet
Postadresse: Lovisenberggata 8
Postnummer: 0456
Poststed: Oslo
Kontakt
Internettadresse: http://www.fhi.no 🌏
E-post: ole.andreas.fuglesang@fhi.no 📧
Telefon: +47 21076629 📞
URL for dokumenter: http://eu.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=276019&B=DFO 🌏
URL for deltakelse: http://eu.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=276019&B=DFO 🌏

Referanse
Datoer
Sendt dato: 2020-07-22 📅
Innleveringsfrist: 2020-09-28 📅
Publiseringsdato: 2020-07-24 📅
Identifikatorer
Kunngjøringsnummer: 2020/S 142-350743
OJ-S-utgave: 142
Tilleggsinformasjon
Two representatives from the Norwegian Institute of Public Health.

Gjenstand
Anskaffelsens omfang
Kort beskrivelse:
Folkehelseinstituttet [the Norwegian Institute of Public Health] is carrying out an open tender competition with the aim of entering into a framework agreement for the delivery of MMR vaccines. I.e. a combination vaccine against measles, mumps and rubella (living) for the Norwegian Childhood Immunisation Programme.
Vis mer
The competition is carried out as an open tender competition in accordance with the Public Procurement Regulations' Parts 1 and 3. The competition is implemented electronically in the CTM electronic tender documentation tool (Norwegian abbreviation: KGV).
Vis mer
There are four (4) minimum requirements for the vaccine.
The agreement includes the delivery of a combination vaccine against measles, mumps and rubella (living) (MMR) (ATC code: J07B D52)
The new agreement is valid from 1 June 2021. The contract will have a duration of 2 years with automatic extension for 1 year + 1 year unless it is cancelled earlier in-line with supply agreement point 17.
The delivery includes 540 000-660 000 doses during the maximum agreement period (4 years).
Estimert totalverdi: 40 000 000 NOK 💰
Estimert verdi eksklusive mva: 40 000 000 NOK 💰
Varighet: 24 måneder
Beskrivelse av fornyelser:
The agreement period is 2 years with an automatic extension for 1 year + 1 year unless it is cancelled earlier in-line with supply agreement point 17. The contracting authority aims to sign the agreement shortly after the procurement is implemented.
Beskrivelse av opsjoner:
The agreement period is 2 years with an automatic extension for 1 year + 1 year unless it is cancelled earlier in-line with supply agreement point 17. The contracting authority aims to sign the agreement shortly after the procurement is implemented.
Utførelsessted
Hovedsted eller utførelsessted: Oslo.

Juridisk, økonomisk, finansiell og teknisk informasjon
Vilkår for deltakelse
Egnethet til å utøve yrkesvirksomheten:
The tenderer must be registered in a company register, professional register or a trade register in the state where the tenderer is established.
Documentation requirement:
Norwegian tenderers: company registration certificate,
Foreign tenderers: verification showing that the tenderer is registered in a company register, professional register or a commerce register in the country where the tenderer is established.
Økonomisk og finansiell stilling:
Sufficient economic and financial capacity to be able to fulfil the contract. Creditworthiness with no requirement for guarantees will be sufficient to meet the requirement.
Documentation requirement:
Credit rating based on the most recent accounting figures. The rating must be carried out by a credit rating company with a license to conduct this service. If a tenderer has valid reasons for not being able to provide the documentation requested by the contracting authority, the tenderer can prove his economic and financial position with any other document that the contracting authority deems suitable.
Vis mer
Teknisk og faglig kapasitet:
Tenderers must have experience from comparable assignments.
Documentation requirement:
Description of up to three of the tenderer's most relevant assignments during the last 3 years. The description must include an indication of the assignment product/scope or value, dates and recipients. It is the tenderer's responsibility to confirm relevance through the description.
Vis mer
The tenderer must have sufficient delivery capacity throughout the contract period.
Proof that the tenderer has the capacity to deliver up to 165 000 doses of MMR vaccine per year through the agreement period.
The tenderer must have the requisite permissions to be able to fulfil the contract.
If the tenderer is the manufacturer of the vaccine, permission must be presented from relevant EU/EEA authorities to manufacture pharmaceuticals.
If the tenderer is not the manufacturer of the vaccine, the requisite permissions from relevant EU/EEA authorities to trade in pharmaceuticals must be presented.
If the tenderer imports the vaccine, the import license that includes the offered vaccine must be presented.
Kontraktutførelse
Vilkår for kontraktoppfyllelse:
The Norwegian Institute of Public Health requires ethical and socially responsible production. (Supply Agreement, point 12, 12.1 — 12.4).
The tenderer shall be a member of the Legemiddelansvarsforeningen [Pharmaceutical Liability Association] (Supply Agreement, point 11.2).
The Norwegian Institute of Public Health can re-sell, non-distributed, vaccine doses (Supply agreement, point 18.1).
The tenderer must be able to deliver up to 165 000 doses per year during the agreement period (Supply agreement point 3.3).
The Norwegian Institute of Public Health is obliged to procure a minimum of 135 000 doses per year during the agreement period (Supply agreement point 3.2).

Prosedyre
Rettslig grunnlag: 32014L0024
Tidspunkt for mottak av tilbud: 13:00
Språk som tilbud eller forespørsler om deltakelse kan sendes inn på: engelsk 🗣️
norsk 🗣️
Tilbudets gyldighetsperiode: 2020-11-28 📅
Dato for åpning av tilbud: 2020-09-28 📅
Tidspunkt for åpning av tilbud: 13:30
Sted: The tenders will be opened electronically in the CTM system.
Tilleggsinformasjon: Two representatives from the Norwegian Institute of Public Health.

Oppdragsgiver
Identitet
Nasjonalt registreringsnummer: 983 744 516
Kontakt
Kontaktpunkt: Ole Andreas Fuglesang
Adresse til kjøperprofilen: https://eu.eu-supply.com/ctm/Company/CompanyInformation/Index/346372 🌏
URL for dokumenter: http://eu.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=276019&B=DFO 🌏

Utfyllende informasjon
Klageinstans
Navn: Oslo Tingrett
Postadresse: Postboks 2106 Vika
Poststed: Oslo
Postnummer: 0125
Land: Norge 🇳🇴
Telefon: +47 22035200 📞
E-post: oslo.tingrett@domstol.no 📧
Internettadresse: https://www.domstol.no/Enkelt-domstol/oslotingrett/ 🌏
Organ ansvarlig for meklingsprosedyrer
Navn: KOFA — Klagenemnda for Offentlige Anskaffelser
Postadresse: Postboks 511 Sentrum
Poststed: Bergen
Postnummer: 5805
Telefon: +47 55193000 📞
E-post: post@knse.no 📧
Internettadresse: www.kofa.no 🌏
Kilde: OJS 2020/S 142-350743 (2020-07-22)
Kunngjøring om tildeling av kontrakt (2021-01-15)
Gjenstand
Anskaffelsens omfang
Kort beskrivelse:
The Norwegian Institute of Public Health has held an open tender contest with the aim of entering into a framework agreement for the delivery of MMR vaccines. I.e., a combination vaccine against measles, mumps, and rubella (living) for the Norwegian Childhood Immunisation Programme. The contest was held as an open tender contest in accordance with the Public Procurement Regulations, Parts 1 and 3. The contest was held electronically in the CTM electronic tender documentation tool (Norwegian abbreviation: KGV). There were four (4) minimum requirements for the vaccine. The agreement includes the delivery of a combination vaccine against measles, mumps, and rubella (living) (MMR) (ATC code: J07B D52) The new agreement is valid from 1 June 2021. The contract will have a duration of 2 years with automatic extension for 1 year + 1 year unless it is cancelled earlier in-line with Supply Agreement point 17. The delivery includes 540 000-660 000 doses during the maximum agreement period (4 years).
Vis mer
Totalverdi for anskaffelsen: 40 000 000 NOK 💰
Metadata for kunngjøring
Dokumenttype: Kunngjøring om tildeling av kontrakt

Prosedyre
Tilbudstype: Ikke aktuelt

Referanse
Datoer
Sendt dato: 2021-01-15 📅
Publiseringsdato: 2021-01-20 📅
Identifikatorer
Kunngjøringsnummer: 2021/S 013-029262
Refererer til kunngjøring: 2020/S 142-350743
OJ-S-utgave: 13
Tilleggsinformasjon
Pursuant the Act relating to public access to documents in public administration Section 13 and the Public Administration Act Section 13, first section 2), the contract sum is not given in the tender notice. The vaccines' price per dosage is the only price element. The contracting authority has come the conclusion that if the contract value is given with information of the extent/volume in the tender documentation, it will be possible to calculate the price per dosage. The contracting authority considers offered prices per dosages as information that must be kept secret due for competitive reasons.
Vis mer

Gjenstand
Anskaffelsens omfang
Kort beskrivelse:
The Norwegian Institute of Public Health has held an open tender contest with the aim of entering into a framework agreement for the delivery of MMR vaccines. I.e., a combination vaccine against measles, mumps, and rubella (living) for the Norwegian Childhood Immunisation Programme.
Vis mer
The contest was held as an open tender contest in accordance with the Public Procurement Regulations, Parts 1 and 3. The contest was held electronically in the CTM electronic tender documentation tool (Norwegian abbreviation: KGV).
There were four (4) minimum requirements for the vaccine.
The agreement includes the delivery of a combination vaccine against measles, mumps, and rubella (living) (MMR) (ATC code: J07B D52)
The new agreement is valid from 1 June 2021. The contract will have a duration of 2 years with automatic extension for 1 year + 1 year unless it is cancelled earlier in-line with Supply Agreement point 17.
The contest was held as an open tender competition in accordance with the Public Procurement Regulations, Parts 1 and 3. The contest was held electronically in the CTM electronic tender documentation tool (Norwegian abbreviation: KGV).
The agreement includes the delivery of a combination vaccine against measles, mumps, and rubella (living) (MMR) (ATC code: J07B D52).
Beskrivelse av opsjoner:
The agreement period is 2 years with an automatic extension for 1 year + 1 year unless it is cancelled earlier in-line with Supply Agreement point 17.

Tildeling av kontrakt
Dato for kontraktinngåelse: 2020-12-17 📅
Navn: MSD (Norge) AS
Nasjonalt registreringsnummer: 921 386 540
Postadresse: Grønland 51
Poststed: Drammen
Postnummer: 3045
Land: Norge 🇳🇴
E-post: terje.kvale@merck.com 📧
Totalverdi for anskaffelsen: 1 NOK 💰
Informasjon om tilbud
Antall mottatte tilbud: 1

Utfyllende informasjon
Klageinstans
Navn: Oslo tingrett
Organ ansvarlig for meklingsprosedyrer
KOFA - Klagenemnda for offentlige anskaffelser
Kilde: OJS 2021/S 013-029262 (2021-01-15)
Nye anskaffelser i relaterte kategorier 🆕
Relaterte søk 🔍
Produkter/tjenester:
Medisinsk utstyr, legemidler og utstyr... Farmasøytiske produkter Antiinfektive midler for systemisk bruk,... Antiinfektive midler for systemisk bruk Vaksiner Vaksiner mot meslinger, kusma og røde hunder